Table: Delta-Fly Pharma -2021/22 parent forecast
Mar 8 (Reuters) -
Delta-Fly Pharma, Inc.
PARENT- ONLY EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2022 Mar 31, 2022
LATEST PREVIOUS
FORECAST FORECAST
Sales 300 mln 100 mln
Operating loss 1.10 loss 1.30
Recurring loss 1.10 loss 1.30
Net loss 1.10 loss 1.30
EPS loss 203.08 yen loss 239.87 yen
NOTE - Delta-Fly Pharma, Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T